Centauri story featured in Sunday Times

March 20, 2022 | News
Centauri's story through an interview with CSO Dr Mike Westby was featured in a Sunday Times article written by Sabah Meddings.

Centauri awarded follow-on CARB-X grant

February 22, 2022 | News
Centauri Therapeutics Limited, an immunotherapy company focused on the treatment of infectious diseases, has been awarded a grant of up to $2.7 million USD (c.£2…

Centauri Therapeutics closes £24m Series A investment round

January 26, 2022 | News
Centauri Therapeutics is delighted to announce new investment of £24m in antimicrobial research and appointment of new company directors. See attached press release